Gabelli Funds LLC grew its holdings in shares of Cigna Holding Co (NYSE:CI) by 143.6% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 84,902 shares of the health services provider’s stock after purchasing an additional 50,052 shares during the quarter. Gabelli Funds LLC’s holdings in Cigna were worth $16,125,000 as of its most recent filing with the Securities and Exchange Commission.
Several other institutional investors have also added to or reduced their stakes in CI. Capital World Investors grew its stake in Cigna by 172.7% in the 3rd quarter. Capital World Investors now owns 5,464,526 shares of the health services provider’s stock valued at $1,137,988,000 after buying an additional 3,460,726 shares during the last quarter. Capital Research Global Investors acquired a new position in Cigna in the 3rd quarter valued at $682,210,000. Ruffer LLP acquired a new position in Cigna in the 3rd quarter valued at $302,517,000. FMR LLC grew its stake in Cigna by 18.6% in the 3rd quarter. FMR LLC now owns 8,970,440 shares of the health services provider’s stock valued at $1,868,093,000 after buying an additional 1,409,335 shares during the last quarter. Finally, Point72 Asset Management L.P. grew its stake in Cigna by 706.3% in the 3rd quarter. Point72 Asset Management L.P. now owns 927,292 shares of the health services provider’s stock valued at $193,109,000 after buying an additional 812,292 shares during the last quarter. Institutional investors and hedge funds own 93.55% of the company’s stock.
NYSE CI opened at $186.45 on Wednesday. The company has a current ratio of 0.42, a quick ratio of 0.98 and a debt-to-equity ratio of 0.96. The firm has a market capitalization of $46.78 billion, a price-to-earnings ratio of 13.11, a P/E/G ratio of 0.86 and a beta of 0.72. Cigna Holding Co has a 52-week low of $163.02 and a 52-week high of $226.60.
Cigna (NYSE:CI) last posted its quarterly earnings results on Friday, February 1st. The health services provider reported $2.46 earnings per share (EPS) for the quarter, missing the consensus estimate of $2.53 by ($0.07). The company had revenue of $13.75 billion during the quarter, compared to analyst estimates of $11.38 billion. Cigna had a return on equity of 16.64% and a net margin of 5.42%. The business’s revenue for the quarter was up 29.3% on a year-over-year basis. During the same quarter in the prior year, the business earned $1.94 earnings per share. Research analysts forecast that Cigna Holding Co will post 16.36 EPS for the current fiscal year.
In other news, Director William D. Zollars sold 201 shares of Cigna stock in a transaction dated Friday, December 14th. The shares were sold at an average price of $210.84, for a total transaction of $42,378.84. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Company insiders own 1.10% of the company’s stock.
A number of research firms recently issued reports on CI. Zacks Investment Research upgraded shares of Cigna from a “hold” rating to a “buy” rating and set a $208.00 target price on the stock in a research note on Friday, January 4th. Goldman Sachs Group reiterated a “buy” rating on shares of Cigna in a research note on Saturday. ValuEngine upgraded shares of Cigna from a “sell” rating to a “hold” rating in a research note on Thursday, January 3rd. BMO Capital Markets raised their target price on shares of Cigna from $220.00 to $230.00 and gave the company a “hold” rating in a research note on Friday, November 2nd. Finally, Morgan Stanley lowered their target price on shares of Cigna from $304.00 to $299.00 and set an “overweight” rating on the stock in a research note on Tuesday. Four research analysts have rated the stock with a hold rating and fourteen have issued a buy rating to the stock. The stock presently has an average rating of “Buy” and an average price target of $229.09.
Cigna Company Profile
Cigna Corporation, a health services organization, provides insurance and related products and services in the United States and internationally. It operates through Global Health Care, Global Supplemental Benefits, Group Disability and Life, and Other Operations segments. The Global Health Care segment offers medical, dental, behavioral health, vision, and prescription drug benefit plans, as well as health advocacy programs, and other products and services to insured and self-insured customers.
Featured Story: Cost of Goods Sold (COGS)
Receive News & Ratings for Cigna Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna and related companies with MarketBeat.com's FREE daily email newsletter.